Clinical Trial Update: A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours [Phase 3]

View source ↗

Summary

A Phase 3 bioequivalence study of docetaxel injection in patients with solid tumours has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumours

Drugs mentioned

• Docetaxel injection (docetaxel)

Snippet

Sponsor: Zhuhai Beihai Biotech Co., Ltd | Conditions: Docetaxel, Solid Tumours | Phase 3 | Status: COMPLETED